Kenan-Flagler School of Business, The University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
Competition Policy & Advocacy Section, Antitrust Division, U.S. Department of Justice, Washington, DC, USA.
J Med Syst. 2020 Mar 5;44(4):80. doi: 10.1007/s10916-020-01553-2.
In light of recent health policy efforts to promote price transparency, this perspective reviews the challenges and benefits of price transparency. These price transparency efforts include the recent executive order and associated rulemaking directing providers to disclose negotiated and out-of-pocket costs for "shoppable" healthcare services. First, we explore the previous efforts of states and health plans targeted at price transparency, reviewing lessons for future implementation. Second, we address the value of price transparency in light of various policy concerns and objections. Finally, we jointly hypothesize potential effects of and opportunities presented by price transparency for patients, physicians, and other healthcare industry stakeholders.
鉴于最近卫生政策在促进价格透明度方面的努力，本观点回顾了价格透明度的挑战和益处。这些价格透明度工作包括最近的行政命令和相关的规则制定，要求供应商披露“可购买”医疗服务的协商和自付费用。首先，我们探讨了各州和健康计划在价格透明度方面的先前努力，总结了未来实施的经验教训。其次，我们根据各种政策关注和反对意见来探讨价格透明度的价值。最后，我们共同假设价格透明度对患者、医生和其他医疗保健行业利益相关者的潜在影响和机遇。
